Sony
launches PlayStation 3 in US
New York:
Sony Corp has launched the latest version of its iconic
game' PlayStation 3 amid much hype and expectations from
consumers.
Sony
has otherwise had a tough year recalling nearly 10m of
its computer batteries, delays in the PS3 and a growing
price war in the flat screen TV market.
Sony's
PlayStation is expected to bring in Sony's much needed
profits as each PlayStation will sell for $500 or $600
and 400,000 units of the PlayStation are expected to be
available one week after an initial launch in Japan.
Sony
is expected to lose money initially on each sale of the
PS3, which in addition to playing games, can surf the
Web, download video and music and play movies with its
Blu-ray high-definition disc drive. The Blu-ray player
and other components have run up production costs, dragging
Sony's game unit into a loss for the year to March.
PS3
is expected to last 10 years and could go a long way toward
helping Sony meet its goal of staying at the top of the
$30bn gaming market, as well as make Blu-ray the standard
for next-generation DVD.
Back
to News Review index page
George
Bush approves Alcatel takeover of Lucent
Washington: President George W. Bush has approved
a deal in which French telecommunications equipment maker
Alcatel SA will acquire Lucent Technologies Inc. in an
$11.8 billion deal, despite concerns about safeguards
for classified work that Lucent's Bell Laboratories conducts
for the U.S. government.
The
companies have promised to create a separate unit run
by Americans to handle sensitive U.S. contracts.
The
combination of Alcatel and Lucent would create one of
the world's biggest suppliers of network hardware and
software for mobile and high-speed Internet communications,
with $25 billion in annual revenue.
Back
to News Review index page
Pfizer
files case against Chinese co over Viagra
Beijing: US pharmaceutical giant Pfizer has filed
a case against a Chinese pharmaceutical company over infringing
its copyright for its erectile dysfunction drug Viagra
according to reports in the Chinese media.
The
legal action came after New York-based Pfizer won a court
ruling upholding its China patent for Viagra in June.
Pfizer had originally obtained a Chinese patent license
for Viagra in 2001.
However
the country's patent review board, the State Intellectual
Property Office, revoked the license in July 2004 following
complaints by 12 Chinese pharmaceutical companies. The
patent review board claimed Pfizer was in breach of intellectual
property law because it failed to accurately explain the
uses of the pill's key ingredient, sildenafil citrate.
However
the Beijing Intermediate court ruling in June reversed
the review board's verdict.
The
Chinese drug companies from various cities around the
country claim to have invested over 100 million yuan (USD
12 million) in less expensive imitations of the little
blue pill.
Back
to News Review index page
Half
of drugs sold online likely to be fake
New York: A United Nations-led task force has said
50 per cent of the drugs sold online may be counterfeit
which could promote drug resistant strains of the disease,
worsen medical conditions and even kill patients. The
task force has also called for strengthening laws to deal
with such online pharmacies to curb the multi-billion
dollar market in fake drugs.
The
United Nations World Health Organization along with more
than 20 international partners inaugurated the International
Medical Products Anti-Counterfeiting Task Force (IMPACT)
in Bonn, Germany, to seek stricter law enforcement by
various countries, stronger regulations and use of technology
to rein in fake drug market which in some parts of the
world account for 30 per cent of the total market.
Counterfeit
medicines range from products containing no active ingredients
to those with highly toxic substances. The legal systems
of most countries do not consider the problem a more serious
crime than counterfeiting luxury items such as handbags
or watches, WHO said.
National
laws are designed more to protect trademarks than people's
health and in some industrialized countries, counterfeiting
T-shirts receives a harsher punishment than counterfeiting
medicines.
Back
to News Review index page
|